Transcriptome analysis in endobronchial epithelial lining fluid compared to bronchoalveolar lavage in idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015
Morphological changes of large bronchi in sarcoidosis (analysis of biopsy specimens) Source: Eur Respir J 2001; 18: Suppl. 33, 384s Year: 2001
Pleural fluid ‘cell block’ analysis in malignant pleural effusion: sensitive, superior over fluid cytology and suitable for immunohistochemistry analysis (IHC), will decrease need for thoracoscopy guided procedures Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017
Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013
The evaluation of clarithromycin (CAM) in bronchial epithelial lining fluid (ELF) using bronchoscopic microsampling (BMS) probes is useful in the management of patients with pulmonary Mycobacterium avium complex (MAC) Source: Eur Respir J 2005; 26: Suppl. 49, 454s Year: 2005
Comparative evaluation of the diagnostic value of serum tumor markers versus those identified in bronchial lavage fluid in patients with histologically confirmed bronchial carcinoma Source: Eur Respir J 2003; 22: Suppl. 45, 256s Year: 2003
Diagnostic comparison between pleural fluid cytology (PFC), cellular block (CB) and pleural biopsy (PB) under visual guidance Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011
Immunocytological study of bronchioloalveolar lavage (BAL) in interstitial lung diseases (ILD) diagnosis Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound Year: 2018
Conventional vs ultrathin bronchoscopy in the diagnosis of solitary pulmonary nodules (SPN) Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions Year: 2013
A gene network to predict the clinical response to whole lung lavage (WLL), in pulmonary alveolar proteinosis (PAP). Source: International Congress 2017 – Novel and old entities Year: 2017
Inflammatory cell quantification in bronchial biopsies (BB) in COPD: evaluation to 100 microns depth vs all intact subepithelium Source: Eur Respir J 2002; 20: Suppl. 38, 403s Year: 2002
Blind bronchoscopic lung biopsy (BLB) as a primary approach to the evaluation of peripheral lung lesions Source: Annual Congress 2009 - Trends in bronchoscopy Year: 2009
Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusions Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012
Contribute of BAL proteomic analysis in sarcoidosis (S) and in idiopathic pulmonary fibrosis (IPF/UIP) Source: Eur Respir J 2006; 28: Suppl. 50, 564s Year: 2006
Biomarker discovery in chronic obstructive pulmonary disease (COPD) using epithelial lining fluid: A proteomic approach Source: Annual Congress 2011 - Phenotyping airway diseases Year: 2011
Characterization of the gene network driving the whole lung lavage (WLL) outcome in Pulmonary Alveolar Proteinosis (PAP). Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018
Diagnostic value of induced sputum (IS) in interstitial lung disease (ILD) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007
Flow cytometry (FC) applied to bronchoalveolar lavage lymphocyte (L-BAL) analyses as auxiliary diagnostic tool in interstitial lung diseases (ILD) Source: Eur Respir J 2003; 22: Suppl. 45, 226s Year: 2003
Tumour marker (TM) CA 19-9 in pleural fluid at patients with malignant and paramalignant pleural effusion (PE) Source: Eur Respir J 2001; 18: Suppl. 33, 387s Year: 2001
The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013